drugset / Trial / NCT04446637

Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD

NCT04446637

Phase 3 Withdrawn Neutec Ar-Ge San ve Tic A.Ş
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare acute bronchodilator effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination (2 inhalations) via pMDI and Salbutamol 100 mcg Inhaler (2 inhalations) plus Ipratropium 20 mcg Inhalation Aerosol (2 inhalations) Free Combination in Patients with stable moderate-severe-very severe COPD.

Timeline

Start
2021-09-03
Primary completion
2022-09-03
Completion
2022-09-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 20 ug Inhaled
Subject Levalbuterol Other / unclassified 50 ug Inhaled
Comparator Salbutamol Unknown 100 ug Inhaled